Tasly Pharmaceutical Group Co Ltd (600535) — Free Cash Flow Generation Index
Tasly Pharmaceutical Group Co Ltd (600535) has a Free Cash Flow Generation Index of 0.79x as of December 2025. Free cash flow of CN¥434.36 Million represents 1% of operating cash flow (CN¥552.13 Million). See working capital position of Tasly Pharmaceutical Group Co Ltd to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Tasly Pharmaceutical Group Co Ltd Free Cash Flow Generation Index (2001–2025)
Historical FCF Generation Index trend for Tasly Pharmaceutical Group Co Ltd across 24 annual periods. Explore 600535 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Tasly Pharmaceutical Group Co Ltd (2001–2025)
Year-by-year Free Cash Flow Generation Index for Tasly Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see 600535 stock market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.73x | CN¥1.04 Billion | CN¥1.42 Billion | CN¥381.26 Million | ▲ +1.8% |
| 2024 | 0.72x | CN¥1.45 Billion | CN¥2.01 Billion | CN¥564.94 Million | ▼ -2.8% |
| 2023 | 0.74x | CN¥1.91 Billion | CN¥2.58 Billion | CN¥668.82 Million | ▼ -10.1% |
| 2022 | 0.82x | CN¥1.88 Billion | CN¥2.29 Billion | CN¥403.45 Million | ▲ +3.5% |
| 2021 | 0.80x | CN¥2.23 Billion | CN¥2.80 Billion | CN¥571.73 Million | ▲ +3.1% |
| 2020 | 0.77x | CN¥1.38 Billion | CN¥1.79 Billion | CN¥408.81 Million | ▲ +36.6% |
| 2019 | 0.57x | CN¥949.37 Million | CN¥1.68 Billion | CN¥730.78 Million | ▲ +18.3% |
| 2018 | 0.48x | CN¥713.69 Million | CN¥1.49 Billion | CN¥780.10 Million | ▼ -12.4% |
| 2016 | 0.55x | CN¥629.05 Million | CN¥1.15 Billion | CN¥524.68 Million | ▲ +146.6% |
| 2015 | -1.17x | CN¥-397.84 Million | CN¥340.00 Million | CN¥737.84 Million | ▼ -422.3% |
| 2014 | -0.22x | CN¥-138.17 Million | CN¥616.76 Million | CN¥754.93 Million | ▲ +75.6% |
| 2013 | -0.92x | CN¥-317.39 Million | CN¥346.17 Million | CN¥663.56 Million | ▼ -1727.2% |
| 2012 | 0.06x | CN¥23.29 Million | CN¥413.31 Million | CN¥390.02 Million | ▲ +102.6% |
| 2011 | -2.13x | CN¥-287.44 Million | CN¥135.14 Million | CN¥422.58 Million | ▼ -467.1% |
| 2010 | 0.58x | CN¥228.92 Million | CN¥395.05 Million | CN¥166.13 Million | ▼ -18.2% |
| 2009 | 0.71x | CN¥283.58 Million | CN¥400.39 Million | CN¥116.80 Million | ▲ +26.5% |
| 2008 | 0.56x | CN¥145.69 Million | CN¥260.21 Million | CN¥114.51 Million | ▲ +510.3% |
| 2007 | 0.09x | CN¥20.33 Million | CN¥221.55 Million | CN¥201.23 Million | ▲ +111.2% |
| 2006 | -0.82x | CN¥-114.84 Million | CN¥140.56 Million | CN¥255.41 Million | ▼ -115.6% |
| 2005 | -0.38x | CN¥-81.43 Million | CN¥214.90 Million | CN¥296.33 Million | ▲ +53.7% |
| 2004 | -0.82x | CN¥-166.35 Million | CN¥203.27 Million | CN¥369.62 Million | ▲ +82.1% |
| 2003 | -4.57x | CN¥-269.74 Million | CN¥59.00 Million | CN¥328.74 Million | ▼ -1276.5% |
| 2002 | 0.39x | CN¥80.13 Million | CN¥206.22 Million | CN¥126.09 Million | ▲ +191.5% |
| 2001 | -0.42x | CN¥-35.59 Million | CN¥83.77 Million | CN¥119.35 Million | — |